Imaging News

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

GE HealthCare announced it received FDA 510(k) clearance of its next-generation image-guided system, designed to optimize imaging at the right dose regardless of patient size, for use during interventional CV procedures.

Women presenting with chest pain but without signs of obstructive coronary disease may still have microvascular dysfunction, and careful imaging analyses or invasive testing can help reveal the correct diagnosis, according to a speaker.

Arineta Cardio Imaging announced the FDA 510(k) clearance and launch of its next generation cardiovascular CT scanners.

Adults undergoing chimeric antigen receptor T-cell therapy are at low risk for major adverse cardiovascular events, according to data published in JACC: CardioOncology.

Confirming a previous report, PET with a novel radiotracer had good sensitivity and specificity for CAD detection and outperformed single-photon emission CT myocardial perfusion imaging.

Researchers reported that HF was independently prognostic of both cardiac and cerebral microvascular dysfunction predictive of impaired cognitive function.

A comprehensive strategy involving shared cardiac PET scans was associated with better CV outcomes compared with standard care in patients with suspected CAD, according to the results of the CENTURY trial.

Data suggest that left atrial scarring observed with 2D long-axis MRI is associated with adverse atrial remodeling and incident clinically detected atrial fibrillation, researchers reported.

Boston Scientific announced the FDA clearance of its next-generation IVUS and fractional flow reserve system designed improve guidance during PCI.